医学
食品药品监督管理局
药品审批
药品
批准的药物
药理学
重症监护医学
作者
Alex M. Ebied,Hesham Elmariah,Rhonda M Cooper-DeHoff
标识
DOI:10.1016/j.amjmed.2022.01.055
摘要
Abstract
In 2021, the US Food and Drug Administration (FDA) approved 50 novel drugs. Thirty-seven of the 50 (74%) novel drug approvals were reviewed and approved through an expedited review pathway, and 26 of the 50 (52%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2021.
科研通智能强力驱动
Strongly Powered by AbleSci AI